New Obesity Treatment in Development: A First-of-Its-Kind Approach from Genentech and Hanmi Pharm
A potential new treatment for obesity, called HM17321, is being developed by Genentech (a part of the Roche Group) and […]
Pharmaceutical News
FDA Approves First HIV Treatment for Newborns Weighing Just 2 kg
ViiV Healthcare has received approval from the U.S. Food and Drug Administration (FDA) for a new version of the HIV
Pharmaceutical News
New EU-Approved Medicine for Rett Syndrome Offers Hope for Children and Families
A new medication called Daybu (trofinetide) has been approved in Europe for children aged five and older who have Rett
New Alzheimer’s Treatment Available in a Convenient Once-Weekly Injection
Eisai and Biogen have introduced a new form of the Alzheimer’s medication Leqembi called Leqembi Iqlik. This version comes as
Pharmaceutical News
UK Regulator Sets Clear Rules for New Microbiome Medicines to Fight Superbugs
A new guidance document from the UK’s medicines regulator, the MHRA, has laid out a clear path for companies to
Pharmaceutical News
FDA Approves New Targeted Treatment for Advanced Pancreatic Cancer
A major breakthrough in cancer treatment has been approved by the U.S. Food and Drug Administration (FDA) for patients with
Pharmaceutical News
Why Strong Data Integrity Is Critical for Safe and Reliable Medicines
Pharmaceutical quality control labs are under increasing pressure to improve how they handle data to meet strict regulatory standards. Poor
FDA Approves Avulux Lenses to Help Manage Light Sensitivity in People with Migraine
A new type of eyeglass lens called Avulux has been approved by the U.S. Food and Drug Administration (FDA) to
New Drug Combination Shows Promise for Lung Cancer Patients After Standard Treatment Fails
A recent clinical trial called Saffron has found that combining two existing cancer drugs, Orpathys (savolitinib) and Tagrisso (osimertinib), can
New Study Shows Promise for a Simpler Treatment for Generalized Anxiety Disorder
Definium Therapeutics has shared good news from their first major trial (called Voyage) of a new fast-dissolving tablet called DT120